Literature DB >> 35099676

Most Probable Druggable Pockets in Mutant p53-Arg175His Clusters Extracted from Gaussian Accelerated Molecular Dynamics Simulations.

Morad Mustafa1, Mohammed Gharaibeh2.   

Abstract

p53, a tumor suppressor protein, is essential for preventing cancer development. Enhancing our understanding of the human p53 function and its modifications in carcinogenesis will aid in developing more highly effective strategies for cancer prevention and treatment. In this study, we have modeled five human p53 forms, namely, inactive, distal-active, proximal-active, distal-Arg175His mutant, and proximal-Arg175His mutant forms. These forms have been investigated using Gaussian accelerated molecular dynamics (GaMD) simulations in OPC water model at physiological temperature and pH. Our observations, obtained throughout [Formula: see text] of production run, are in good agreement with the relevant results in the classical molecular dynamics (MD) studies. Therefore, GaMD method is more economic and efficient method than the classical MD method for studying biomolecular systems. The featured dynamics of the five human p53-DBD forms include noticeable conformational changes of L1 and [Formula: see text]-[Formula: see text] loops as well as [Formula: see text]-[Formula: see text] and [Formula: see text]-[Formula: see text] turns. We have identified two clusters that represent two distinct conformational states in each p53-DBD form. The free-energy profiles of these clusters demonstrate the flexibility of the protein to undergo a conformational transition between the two clusters. We have predicted two out of seven possible druggability pockets on the clusters of the Arg175His forms. These two druggability pockets are near the mutation site and are expected to be actual pockets, which will be helpful for the compound clinical progression studies.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Arg175His mutation; Free-energy analysis; Gaussian accelerated molecular dynamics; Principal component analysis; Probable druggable pockets; p53 monomer

Mesh:

Substances:

Year:  2022        PMID: 35099676     DOI: 10.1007/s10930-022-10041-0

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  62 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.

Authors:  P D Jeffrey; S Gorina; N P Pavletich
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

Review 3.  Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities.

Authors:  Bo Hong; A Pieter J van den Heuvel; Varun V Prabhu; Shengliang Zhang; Wafik S El-Deiry
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

Review 4.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Authors:  Flore Kruiswijk; Christiaan F Labuschagne; Karen H Vousden
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07       Impact factor: 94.444

5.  G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms.

Authors:  Virginie Marcel; Phong L T Tran; Charlotte Sagne; Ghyslaine Martel-Planche; Laurence Vaslin; Marie-Paule Teulade-Fichou; Janet Hall; Jean-Louis Mergny; Pierre Hainaut; Eric Van Dyck
Journal:  Carcinogenesis       Date:  2010-11-26       Impact factor: 4.944

Review 6.  The tumor suppressor p53: from structures to drug discovery.

Authors:  Andreas C Joerger; Alan R Fersht
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02-10       Impact factor: 10.005

7.  The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.

Authors:  N P Pavletich; K A Chambers; C O Pabo
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

Review 8.  Modes of p53 regulation.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

Review 9.  Structural biology of the tumor suppressor p53.

Authors:  Andreas C Joerger; Alan R Fersht
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

10.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.